Thursday, January 22, 2009 8:36:47 PM
The rule applies to all directors but only to certain officers and employees of an institution. Executive officers of the institution, as well as investor relations and public relations personnel, are covered in all instances, as are other officers, employees and agents who communicate regularly with the types of persons to whom Regulation FD applies. An institution can adopt a policy that can help determine the other persons to whom Regulation FD applies by providing that only certain individuals are authorized to speak on behalf of the company with respect to financial disclosure matters.
Material, nonpublic information is not defined in the rule and intentionally so. The term “material” has the same definition as in other securities law contexts. It covers information that would be important to the investment decision of a reasonable investor and significantly alters the “total mix” of information available with respect to the particular security.
The rule covers disclosures only to certain types of persons, including broker-dealers, securities analysts and other securities professionals, as well as shareholders in circumstances when it is reasonably foreseeable that they will trade in the company’s securities. The rule specifically exempts communications to employees, although broad communications to an institution’s employee base may precipitate rumors or leaks that create other problems under the securities laws. Regulation FD also exempts advisors to the company such as lawyers, accountants and bankers who owe the company a duty of trust, as well as rating agencies and persons bound by confidentiality agreements. It also excludes by omission persons such as the general media, vendors, customers and business partners.
In certain circumstances, Regulation FD requires that information be publicly released. So far as the rule is concerned, a filing with the SEC on Form 8-K always qualifies as “publicly released.” Short of that, the rule says only that other forms of “broad non-exclusionary distribution to the public” will qualify. Discussion in a conference call covering quarterly earnings qualify, if the call has been properly announced and is open to the public, as a result of the provisions of Item 2.02 of Form 8-K.
The rule requires simultaneous disclosure of matters that are selectively disclosed on an intentional basis. “Simultaneous” appears to mean just that, making it essentially impossible to accomplish. An intentional violation of Regulation FD is, for all practical purposes, not curable—although that does not mean that steps should not be taken to limit the damage.
An intentional selective disclosure means that the person making the disclosure knows that the information is both material and undisclosed or is reckless in not knowing that.
Information that is disclosed selectively on a nonintentional basis must be publicly disclosed promptly. “Promptly” means as soon as practicable but in no event after the later of 24 hours following the disclosure or the next market opening.
Recent RPRX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/23/2026 08:43:18 PM
- Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence • GlobeNewswire Inc. • 03/23/2026 11:15:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/19/2026 09:12:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2026 10:02:29 PM
- Royalty Pharma Announces Expansion of Leadership Team • GlobeNewswire Inc. • 03/17/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:11:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 09:52:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 10:26:17 PM
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform • GlobeNewswire Inc. • 03/02/2026 12:00:00 PM
- Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing • GlobeNewswire Inc. • 03/02/2026 11:10:00 AM
- Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing • GlobeNewswire Inc. • 03/02/2026 11:01:00 AM
- Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 09:08:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2026 10:06:45 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/20/2026 09:27:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:03:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:02:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:02:26 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/11/2026 02:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 12:37:12 PM
- Royalty Pharma Reports Q4 and Full Year 2025 Results • GlobeNewswire Inc. • 02/11/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:07:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/03/2026 10:31:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2026 10:28:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 09:10:58 PM
FEATURED ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • Mar 24, 2026 8:30 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
